Recombinant Escherichia coli Mannose-6-phosphate isomerase (manA)

Shipped with Ice Packs
In Stock

Description

Enzymatic Activity and Biochemical Properties

PMI (EC 5.3.1.8) facilitates the interconversion of Man-6-P and Fru-6-P, enabling organisms to utilize mannose as a carbon source. The recombinant form expressed in E. coli exhibits the following characteristics:

PropertyValueSource
Molecular Mass~119 kDa (predicted from sequence)
Specific Activity≥50 units/mg protein
Optimal pH7.0–7.5
Storage Conditions2–8°C (ammonium sulfate suspension)
Thermal StabilityUp to 75°C (activity retained)

The enzyme’s activity is metal-dependent, with Cu²⁺ enhancing catalytic efficiency in some homologs .

Applications in Metabolic Engineering

Recombinant PMI has enabled breakthroughs in metabolic engineering:

Expansion of Substrate Utilization

  • Zymomonas mobilis: Introduction of E. coli manA into this ethanol-producing bacterium allowed growth on mannose (0.07 h⁻¹) by completing the mannose catabolic pathway . Co-expression with fructokinase (frk) boosted growth rates to 0.25 h⁻¹ .

  • E. coli Mutants: Restored mannose utilization in strains lacking native PMI, confirming the enzyme’s role in central metabolism .

Biotechnology and Therapeutics

  • Plant Transformation: PMI serves as a selectable marker in rice, where it converts toxic Man-6-P into Fru-6-P, enabling transgenic plant survival on mannose-containing media .

  • Enzyme Replacement Therapy: Engineered PMI variants with high mannose-6-phosphate content improve lysosomal targeting in therapies for GM2 gangliosidosis .

Research Findings and Innovations

  • Thermostability: PMI from Thermus thermophilus (homolog of E. coli PMI) retains activity at 75°C, making it suitable for industrial processes .

  • Kinetic Parameters:

    • Km for Man-6-P: 0.37 mM (competitive inhibition by fructose observed in related systems) .

    • Catalytic Efficiency (kcat/Km): Enhanced via mutagenesis (e.g., R142N mutant in T. thermophilus) .

Challenges and Future Directions

  • Substrate Inhibition: High mannose concentrations inhibit PMI activity in some systems, necessitating pathway optimization .

  • Structural Engineering: Designing thermostable or pH-tolerant variants could enhance industrial applicability .

Product Specs

Form
Lyophilized powder. We will ship the available format, but please note any special format requirements when ordering.
Lead Time
Delivery times vary by purchasing method and location. Consult local distributors for specifics. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us for prioritized development.
Synonyms
manA; pmi; b1613; JW1605Mannose-6-phosphate isomerase; EC 5.3.1.8; Phosphohexomutase; Phosphomannose isomerase; PMI
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-391
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12)
Target Names
manA
Target Protein Sequence
MQKLINSVQN YAWGSKTALT ELYGMENPSS QPMAELWMGA HPKSSSRVQN AAGDIVSLRD VIESDKSTLL GEAVAKRFGE LPFLFKVLCA AQPLSIQVHP NKHNSEIGFA KENAAGIPMD AAERNYKDPN HKPELVFALT PFLAMNAFRE FSEIVSLLQP VAGAHPAIAH FLQQPDAERL SELFASLLNM QGEEKSRALA ILKSALDSQQ GEPWQTIRLI SEFYPEDSGL FSPLLLNVVK LNPGEAMFLF AETPHAYLQG VALEVMANSD NVLRAGLTPK YIDIPELVAN VKFEAKPANQ LLTQPVKQGA ELDFPIPVDD FAFSLHDLSD KETTISQQSA AILFCVEGDA TLWKGSQQLQ LKPGESAFIA ANESPVTVKG HGRLARVYNK L
Uniprot No.

Target Background

Function
Converts glucose to GDP-L-fucose, which can be converted to L-fucose, a capsular polysaccharide.
Gene References Into Functions
Transformation with pET-plasmids containing archaeal or bacterial pgi, cpgi, or pgi/pmi genes from the three known PGI families restored growth (PMID: 16046082).
Database Links
Protein Families
Mannose-6-phosphate isomerase type 1 family
Subcellular Location
Cytoplasm.

Q&A

What is Recombinant Escherichia coli Mannose-6-phosphate isomerase (manA) and what is its primary function?

Recombinant Escherichia coli Mannose-6-phosphate isomerase (manA), also known as Phosphomannose isomerase (PMI) or Phosphohexomutase, is an enzyme that catalyzes the interconversion of mannose-6-phosphate to fructose-6-phosphate. This reaction plays a crucial role in carbohydrate metabolism, specifically in the conversion of glucose to GDP-L-fucose, which can subsequently be converted to L-fucose, a capsular polysaccharide. The enzyme serves as an important link between mannose metabolism and glycolysis, enabling cells to utilize mannose as a carbon source by converting it to a glycolytic intermediate .

What is the molecular structure of the recombinant manA protein?

The recombinant manA protein is a full-length protein consisting of 391 amino acids (1-391aa). The commercial recombinant version typically includes an N-terminal 6xHis-SUMO tag to facilitate purification and enhance solubility. The complete amino acid sequence is:

MQKLINSVQNYAWGSKTALTELYGMENPSSQPMAELWMGAHPKSSSRVQNAAGDIVSLRDVIESDKSTLLGEAVAKRFGELPFLFKVLCAAQPLSIQVHPNKHNSEIGFAKENAAGIPMDAAERNYKDPNHKPELVFALTPFLAMNAFREFSEIVSLLQPVAGAHPAIAHFLQQPDAERLSELFASLLNMQGEEKSRALAILKSALDSQQGEPWQTIRLISEFYPEDSGLFSPLLLNVVKLNPGEAMFLFAETPHAYLQGVALEVMANSDNVLRAGLTPKYIDIPELVANVKFEAKPANQLLTQPVKQGAELDFPIPVDDFAFSLHDLSDKETTISQQSAAILFCVEGDATLWKGSQQLQLKPGESAFIAANESPVTVKGHGRLARVYNKL

The molecular weight of the protein is approximately 58.8 kDa, and it typically shows a purity of greater than 90% when analyzed by SDS-PAGE .

How can manA be effectively used as a selectable marker in transformation experiments?

The manA gene encodes phosphomannose isomerase (PMI), which interconverts mannose-6-phosphate to fructose-6-phosphate. This biochemical property makes it an excellent selectable marker for transformation experiments, particularly in plant cells and microbial systems. When using manA as a selectable marker, researchers should follow this methodology:

  • Transform the target cells with a construct containing the manA gene under the control of an appropriate promoter.

  • Plate the transformed cells on media containing mannose as the primary carbon source.

  • Only cells successfully transformed with functional manA will be able to convert mannose-6-phosphate to fructose-6-phosphate, allowing them to utilize mannose for growth.

  • Non-transformed cells lacking manA will be unable to metabolize mannose efficiently, resulting in growth inhibition.

This selection system is advantageous compared to antibiotic-based selection because it uses a metabolic pathway rather than introducing antibiotic resistance, making it more environmentally acceptable for certain applications .

What are the optimal conditions for expressing recombinant manA in E. coli systems?

For optimal expression of recombinant manA in E. coli expression systems, researchers should consider the following parameters:

ParameterRecommended ConditionNotes
E. coli strainBL21(DE3) or similar expression strainsThese strains lack certain proteases and are optimized for recombinant protein expression
Expression vectorpET system with T7 promoterProvides tight regulation and high expression levels
Induction temperature25-30°CLower temperatures can increase soluble protein yield
IPTG concentration0.1-0.5 mMOptimize based on specific construct
Post-induction time4-6 hoursLonger times may be needed at lower temperatures
MediaLB or TB supplemented with glucoseRich media supports higher biomass and protein yield
pH7.0-7.5Maintain pH for optimal enzyme stability

After expression, the recombinant protein can be purified using nickel affinity chromatography targeting the His-tag, followed by optional tag removal depending on the experimental requirements .

How does manA expression affect central carbon metabolism in host organisms?

Phosphomannose isomerase plays a significant role in central carbon metabolism by linking mannose catabolism to glycolysis. When overexpressed in recombinant systems, manA can significantly alter metabolic flux distribution. Research indicates that manA affects key glycolytic enzymes by:

  • Increasing the pool of fructose-6-phosphate available for glycolysis, potentially enhancing glucose consumption rates.

  • Altering the balance between glycolysis and pentose phosphate pathway through its effects on glucose-6-phosphate and fructose-6-phosphate levels.

  • Potentially affecting cellular energy status by modifying glycolytic flux.

Researchers investigating metabolic engineering applications should monitor glycolytic enzyme activities and metabolite concentrations when manipulating manA expression levels to understand the systemic effects on cellular metabolism .

What are the structural determinants of manA substrate specificity and catalytic efficiency?

The substrate specificity of mannose-6-phosphate isomerase is determined by several structural features that influence binding and catalysis. Key aspects include:

  • The active site architecture contains specific residues that coordinate with the phosphate group and hydroxyl groups of the sugar substrate.

  • Metal ion coordination (typically zinc) is essential for the catalytic mechanism.

  • The protein undergoes conformational changes during catalysis that are crucial for proper substrate orientation.

Advanced studies focusing on structure-function relationships might employ site-directed mutagenesis of conserved residues to analyze their contributions to substrate recognition and catalytic efficiency. Recent research suggests that modifications to residues in the substrate-binding pocket can alter the enzyme's preference for mannose-6-phosphate versus other phosphorylated sugars, which has implications for engineering manA variants with novel specificities .

What strategies can resolve common issues in purification of recombinant manA?

Researchers often encounter several challenges when purifying recombinant manA. Here are methodological solutions to common purification issues:

IssuePotential CausesMethodological Solution
Low yieldPoor expression or insolubilityLower induction temperature to 16-20°C; co-express with chaperones; use SUMO fusion tag
Impurities after affinity purificationNon-specific binding to resinInclude 10-20 mM imidazole in binding buffer; increase salt concentration (300-500 mM NaCl)
Loss of enzyme activityProtein denaturation during purificationInclude 10% glycerol in all buffers; maintain temperature at 4°C throughout purification
Protein aggregationImproper buffer conditionsAdd stabilizing agents like 1-5 mM DTT or 0.5-1 mM EDTA; optimize pH (typically 7.0-8.0)
Proteolytic degradationPresence of proteasesAdd protease inhibitors; reduce purification time; keep samples cold

For long-term storage, the enzyme is typically stable in Tris-based buffer with 50% glycerol, maintaining activity for several months when stored at -20°C or -80°C .

How can enzymatic activity assays for manA be optimized for different experimental contexts?

The enzymatic activity of manA can be measured using several approaches, each with specific advantages for different research questions:

  • Spectrophotometric Coupled Assay:

    • Couple the manA reaction with phosphoglucose isomerase and glucose-6-phosphate dehydrogenase

    • Monitor NADPH production at 340 nm

    • Optimal for kinetic analyses and high-throughput screening

  • Mannose Consumption Assay:

    • Measure the decrease in mannose concentration over time using HPLC or enzymatic methods

    • Best for in vivo studies or when analyzing complex mixtures

  • Radiolabeled Substrate Method:

    • Use 14C-labeled mannose-6-phosphate to track conversion

    • Provides highest sensitivity for detecting low activity levels

Optimization considerations include buffer composition (typically HEPES or Tris, pH 7.5-8.0), metal ion concentration (1-5 mM Mg2+ or Mn2+), substrate concentration (0.1-5 mM mannose-6-phosphate), and temperature (typically 25-37°C depending on the research question) .

How does manA function compare between pathogenic and non-pathogenic E. coli strains?

Mannose-6-phosphate isomerase functions across both pathogenic and non-pathogenic E. coli strains, but with notable differences that reflect their evolutionary adaptations. In pathogenic E. coli strains, the enzyme often contributes to capsular polysaccharide biosynthesis, which is crucial for virulence and immune evasion. The enzyme participates in the production of GDP-L-fucose, which becomes incorporated into capsular components.

In contrast, non-pathogenic E. coli (like laboratory K-12 strains) primarily utilize manA for mannose metabolism as a carbon source. Research comparing enzyme characteristics between pathogenic and non-pathogenic strains reveals subtle differences in regulation patterns and metabolic integration that align with their distinct ecological niches. Some pathogenic strains show altered regulation of manA expression in response to environmental signals encountered during host infection .

When designing experiments utilizing manA from different E. coli sources, researchers should consider these functional variations and select the appropriate strain background based on their specific research objectives.

What are the implications of using manA as a selective marker for generating transgenic organisms?

Using the manA gene as a selective marker for generating transgenic organisms offers several methodological advantages and considerations:

  • Positive Selection System: Unlike antibiotic resistance markers that kill non-transformed cells, manA provides a positive selection where only transformed cells can grow on mannose-containing media.

  • Biosafety Advantages: The system does not introduce antibiotic resistance genes into the environment, addressing regulatory and ecological concerns about transgenic organisms.

  • Metabolic Impact Assessment: Researchers must evaluate whether the constitutive expression of manA alters normal carbon metabolism in the host organism through:

    • Metabolomic profiling comparing wild-type and transgenic lines

    • Growth rate comparisons on different carbon sources

    • Analysis of glycolytic intermediates and energy charge

  • Optimization Strategies: Selection efficiency can be improved by:

    • Adjusting mannose concentration in selection media (typically 10-30 g/L)

    • Optimizing osmotic conditions to enhance mannose uptake

    • Including appropriate co-factors for optimal enzyme function

When implementing this selection system, researchers should recognize that high mannose concentrations might be toxic to some cell types even with functional manA, necessitating careful optimization of selection conditions for each host system .

What experimental approaches can reveal structure-function relationships in manA for protein engineering applications?

Investigating structure-function relationships in mannose-6-phosphate isomerase requires a multi-faceted experimental approach:

  • X-ray Crystallography and Cryo-EM Analysis:

    • Determine high-resolution structures of manA in different conformational states

    • Co-crystallize with substrates, products, or inhibitors to identify binding determinants

    • Generate electron density maps to visualize active site architecture

  • Site-Directed Mutagenesis Protocol:

    • Target conserved residues within the active site

    • Create alanine scanning libraries across substrate binding regions

    • Develop rational mutations based on homology modeling predictions

  • Enzyme Kinetics Methodology:

    • Measure Km, kcat, and substrate specificity for wild-type and mutant variants

    • Perform pH and temperature profiles to identify optimal conditions

    • Analyze inhibition patterns to probe binding mechanisms

  • Molecular Dynamics Simulations:

    • Model protein flexibility and substrate interactions

    • Predict effects of mutations before experimental validation

    • Examine conformational changes during catalytic cycle

These approaches collectively provide insights for engineering manA variants with altered substrate specificity, enhanced thermostability, or modified catalytic efficiency for biotechnological applications .

How does recombinant manA interact with central metabolic pathways when expressed in heterologous systems?

When recombinant manA is expressed in heterologous systems, it creates complex interactions with central metabolic pathways that should be carefully analyzed:

Metabolic PathwayInteraction with manAExperimental Detection Method
GlycolysisIncreases flux through fructose-6-phosphate nodeMetabolic flux analysis using 13C-labeled glucose
Mannose metabolismEnables growth on mannose as carbon sourceGrowth rate comparisons on different carbon sources
Pentose phosphate pathwayMay redirect flux from F6P to G6P affecting NADPH productionMeasure NADPH/NADP+ ratios and oxidative stress responses
Cell wall biosynthesisCan affect availability of precursors for peptidoglycan synthesisCell wall composition analysis by HPLC
Capsular polysaccharide productionInfluences GDP-fucose availabilityImmunological detection of surface carbohydrates

Researchers studying these interactions should implement systems biology approaches, including transcriptomics, proteomics, and metabolomics, to comprehensively characterize the impact of manA expression on cellular physiology. This understanding is particularly relevant when using manA in metabolic engineering applications or when studying the physiological role of this enzyme in native systems .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.